Novo Nordisk’s Wegovy Pill Wins U.S. Approval 

Breaking News

BioMarin to Acquire Amicus Therapeutics for $4.8B

BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare diseases.

SPONSOR

Speed & Flexibility: The New CDMO Advantage

Pharma’s future demands faster, more agile partners. See how leading CDMOs like ROIS are adapting to shifting market and regulatory needs.

Breaking News

Senhwa Aims to Enter Global ADC Market with Combination Cancer Therapy

Investigational drug Pidnarulex will be evaluated in combination with antibody-drug conjugate Enhertu in a Phase 1b trial.

Breaking News

EirGenix Licenses Transcenta’s HiCB Platform to Improve Process Efficiency

Combines Transcenta’s continuous biomanufacturing platform and EirGenix’s bioprocessing and CDMO expertise.

SPONSOR

Project Management for CMO Success

This eBook is your guide for navigating partnerships with Contract Manufacturing Organizations (CMOs) in the pharma and biopharma world.

Breaking News

Akari Initiates Manufacturing Activities to Support AKTX-101 Development

WuXi XDC to provide necessary IND-enabling work for AKTX-101 to support the initiation of clinical trials.

SPONSOR

Fill-Finish Outsourcing Trends

CDMO leaders talk about navigating a dynamic landscape of innovation and demand.

Solution Center SPOTLIGHT

FAMAR

FAMAR is a leading European CDMO with over 75 years of experience, providing end-to-end solutions for the pharmaceutical and healthcare industries. With 7 manufacturing sites and 2 R&D centers across Germany, Greece, Italy, and Spain, it delivers quality, compliance and value across a broad portfolio of finished dosage forms.